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ABSTRACT 
 
Doping in performance sport is a complex and controversial issues. The secrecy that characterizes it hinders 
the implementation of epidemiological investigations. It involves the entire society. Moreover, the forces that 
conspire behind doping have always been able not only to identify new substances and new methods but 
also to steal the new scientific discoveries aimed at the treatment of diseases, for their illegal purposes. The 
fight against doping has had a strong push, in 2004, with the birth of the first World Anti-doping Code drafted 
by WADA. The laboratories, the Code, the Biological Passport and the ADAMS are important tools for the 
fight against doping. The aim study is to show the data relating to the consumption of drugs from 2003 to 
2017. A number of the commonly used substances have been discussed and their risks and side effects 
reviewed. Key words: DOPING CONTROLS, DRUGS, SPORT, ANALYSIS, ILLICIT SUBSTANCES, 
LEGISLATION. 
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INTRODUCTION 
 
Sport performance today is the results of many factors, who playing an important role in the athletes’ results 
(Mazzeo et al. 2016; Sjöqvist et al, 2008; Calatayud et al. 2007). 
 
Moreover, Intensity training, talent, and an adequate diet represent the crucial factors for the success of 
athletes (Mazzeo et al 2016). Expert on performance sport define performance sport as the results a specific 
activity, usually competitions, as an extent to which a motor task limited by rules of a given sports discipline 
is accomplished (Altavilla et al, 2017, Raiola, 2017, Raiola, D’Isanto 2017, Tiziana et al, 2017, D’Isanto, 2016, 
Montesano et al, 2013). 
 
The use of drugs to enhance performance in sports has certainly occurred since the time of the original 
Olympic Games [from 776 to 393 BC]. The derivation of the word 'doping' has origin to the Dutch word 'doop,' 
which is a viscous opium juice, the drug of choice of the ancient Greeks (Martínez-Sanz et al. 2017; Mazzeo 
& Volpe, 2016). 
 
It seems that the term doping is derived from an ancient African dialect “doop” as meaning a mixture or a 
potion. The willingness to compromise the performance involved, as victims, even the animals. The Greek 
wrestlers and the Roman gladiators attempted to improve their own performance by taking mixtures of various 
types of plants or by eating sheep’s testicles (Dilger et al, 2007). Doping means athletes taking illegal 
substances to improve their performances. 
 
Moreover, doping is a complex phenomenon analysing the vast variety of substances, supplied through both 
legal and illegal trading routes and the extensive connections between the people involved in the network  
(Esseiva et al., 2007). 
 
Drug abuse is one of the biggest problems in sports. It involves the repeated and excessive use of chemical 
substances to realize a certain effect. It can also be referred to as substance abuse or doping (Mazzeo et al, 
2016). 
 
Doping is increasingly a matter that concerns the whole society: it involves not only elite athletes but amateurs 
too, their friends and relatives, the medical staff, managers, chemists, biologists and pharmacists, 
pharmaceutical industries, clandestine laboratories and criminal organizations (Marclay et al., 2013; Mazzeo 
et al. 2017). The combination of sport and doping arouses negative reactions. An athlete who takes drugs to 
win is guilty of fraud and all the stakeholders immediately dissociate them from a sport not fair: the sponsors, 
for example, rescind their endorsements (Presidenza del Consiglio dei Ministri, 2010). 
 
During the last 2 decades, progress in deciphering the human gene map as well as the discovery of specific 
defective genes encoding particular proteins in some serious human diseases have resulted in attempts to 
treat sick patients with gene therapy (Mazzeo & Volpe, 2016). There has been large attention on human 
recombinant proteins which were gene-engineered and produced in vitro (insulin, insulin-like growth factor-
1, erythropoietin, growth hormone). These substances and methods also became improper tools for 
dishonest athletes (Santamaria S. et al., 2013). In fact, a new frontier reached by the doping is the use of 
genes. 
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According to the Anti-Doping Agency, substances and methods are banned when they meet at least two of 
the three following criteria: they improve performance, pose a threat to athlete health, or no respect the spirit 
of sport (Mazzeo et al. 2016; Santamaria et al. 2013). 
 
The prohibited substances 
The explosive spread of doping has triggered the response of the International Olympic Committee in 1960 
(Botrè, 2008). At beginning, the first anti doping test were sporadic and not completely reliable. Fortunately, 
in 1999, thanks to the creation of the World Anti Doping Agency, it was finally created an organization with 
the sole purpose to fight this “cancer” of sport and consequently the situation of tests is changed (Dvorak J. 
et al. 2014; Valkenburg D. et al. 2014). 
 
The World Anti-Doping Agency (WADA) was an international organization, that is established on November 
10, 1999 with the aim to promote, coordinate, and monitor the fight against doping in sport in all its forms. In 
2004, the aforementioned organization has harmonized the rules and regulations governing anti-doping 
across all sports and all countries for the first time through the issuance of a Code which defines the doping 
(Kayser B. et al., 2005). In accordance with the WADA Code, doping is the presence of a prohibited 
substance or its metabolites or markers’ banned; the use or the attempted use of a prohibited substances or 
a prohibited method; the refusing or the failing, without compelling justification, to submit to sample collection; 
the violation of applicable requirements regarding athlete availability for out-of-competition testing; the 
tampering or the attempting to tamper with any part of doping control; the possession of prohibited 
substances and prohibited methods; the trafficking or the attempted trafficking in any prohibited substance 
or prohibited methods; the administration or the attempted administration to any athlete of any prohibited 
methods or prohibited substances, or the assisting, the encouraging, the aiding, the abetting, the covering 
up or any other type of complicity involving an anti-doping rule violation or any attempted anti-doping rule 
violation. 
 
(WADA, 2017) 
 
The Agency has compiled a list of banned substances and practices that is constantly updated. Now, WADA, 
for example, has identified more than two hundred banned substances currently divided into 10 classes 
(including the class S0) and three methods, as you can see in table 1 (Strano Rossi S., et al. 2011). 
 
The most commonly used substances are androgenic agents such as anabolic steroids. (Mazzeo, 2016). 
These permit athletes to train harder, recover more quickly and build more muscle, but they can lead to 
kidney damage and increased aggression. Anabolic agents, peptide hormones, growth factors and related 
substances and mimetics and beta- 2 agonists are assumed in order to increase the muscle mass (Stiegel 
et al 2010). Moreover, the last two classes of substances and stimulants and the method of manipulation of 
blood and blood components are useful for increasing of endurance and for increasing of reactivity and 
aggression, athletes take stimulants, narcotics, cannabinoids, glucocorticosteroids and alcohol (Strano et al, 
2011). Moreover, in order to mask the assumption of drug, the athletes take hormone and metabolic 
modulators and diuretics and masking agents (Table 1). 
 
Table 1. 2017 Wada prohibited substances and methods 
Substances and methods prohibited in and out competition 
S1 Anabolic agents 
S2 Peptide hormones, growth factors, related substances and mimetics 
S3 Beta- 2 agonists 
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S4 Hormone and metabolic modulators 
S5 Diuretics and masking agents 
M1 Manipulation of blood and blood components  
M2 Chemical and physical manipulation 
M3 Gene doping 
Substances and methods prohibited in competition 
In addition to the categories S1 to S5 and M1 to M3, 
S6 Stimulants 
S7 Narcotics 
S8 Cannabinoids 
S9 Glucocorticosteroids 
Substances prohibited in particular sport 
P1 Alcohol 
P2 Beta-blockers 
 
MATERIALS AND METHODS 
 
This is a descriptive study, consisting of a bibliographic review of the presence of 
substances/metabolites/markers prohibited by the WADA in the Italian sporting context during the period 
2003 -2016. The inclusion criteria were literature search, was performed on PubMed and Scopus database 
and Italy Anti-doping official website. Data showed are originated from the report commissioned by the Italian 
Ministry of Health. Indeed, every year -since 2003- anti-doping tests carry out. Perhaps it is possible to know 
the spread year per year of doping in Italy. The authors have compared the above mentioned data in order 
to show doping’s spread in this period. Table supports the comparison. 
 
RESULTS 
 
The search strategy retrieved have to know that the prohibited substances and/or the amount of substance 
prohibited constantly change: some of them have been eliminated over time while others have been added. 
For example, pseudoephedrine and norephedrine were removed from the list in 2003 but in 2013, the first 
substance was reintroduced with a different dosage. Local anesthetics and caffeine were eliminated in 2004 
(Strano Rossi et al, 2011), even if the substance has been included in the monitoring program of WADA in 
2015. Since 2003, the Commission carried out doping tests. The tests collected only urine samples (Badoud 
et al, 2013; Mazzeo et al. 2017). 
 
Analyzing the consumption of prohibited substances and considered that the control activities of the Anti-
Doping Commission began in April 2003, in that year there was a high consumption of stimulants equal to 
40%. The lowest percentages are 10.3% in 2010 and 6.7% in 2013. Compared with the year 2012, 
consumption fall by 13 percentage points. The average consumption from 2003 to 2016 is 19.3%. 
 
The cannabis derivatives have a peak of consumption in 2005 and 2007, respectively, with 42.6% and 42.3%. 
Their use in the other years is characterized by ups and downs: it should be noted, indeed, that in 2012 the 
percentage is 31.8%, while in 2013 is 16.7%. The lowest consumption occurred in 2014 with the 3%. The 
average consumption is 22.6%. 
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Regarding diuretics and masking agents, they have almost a constant trend over the years. The peak is 
reached in 2014 with 26.7% and in 2008 it was recoded the lowest percentage: 3,4%. The average 
consumption of this type of substances is 16.5%. 
 
Anabolic agents experienced a sharp increase in their consumption in 2010 and 2013, respectively with 
37.1% and 35%. The average consumption is 18.4%%. 
 
Corticosteroids have a peak in 2016 with 21.2% and the lowest consumption in 2007 with 3.8%. The average 
consumption is 9.5%. 
 
Hormones and related substances have a low consumption with 2.1% and spike in consumption in 2008 to 
25.4%. The trend in consumption was fluctuating and the average is 10.4%. 
 
Beta-2 agonists have been banned since 2009. Their peak occurred in 2016 with the 9.1% of consumption 
and, after a brief decline in 2012 by 1.5%. Its average consumption is 4.2%. 
 
Beta-blockers are irrelevant over the years. There are no data for 2013 and its average fuel consumption is 
2.5%. 
 
Another exception should be made for local anesthetics as they were prohibited only in 2003. 
 
Regarding agents with anti-estrogenic activity and narcotics, the consumption has been detected only in few 
years with low percentage (Table 2, Table 3). 
 
Table 2. Consumption of prohibited substances over the years. Breakdown per classes of substances and 
for years. Values are expressed in percentages. Reference period: 2003-2016 
 
* recognized only since 2004 ** not prohibited after 2003 *** recognized from 2009 
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Table 3. Percentage of consumption of prohibited substances over the years. Breakdown per classes of 
substances. Values are expressed in percentages. Reference period: 2003-2016 
 
* recognized only since 2004 ** not prohibited after 2003 *** recognized from 2009 
 
DISCUSSION 
 
Literature shows that the substances that give pleasant sensations or help the subject in his activity will bring 
him to repeat the consumption (Duda et al, 1992; Santamaria S., et al 2014; Stella et al 2005). The reported 
data showed the high consumption of certain drugs ( Striegel H. et al, 2010). Stimulants are used because 
they increase the ability to concentrate, alertness and safety. They also increase the aggressiveness and the 
sense of competitiveness. To anabolic are recognized the following effects: euphoria, sense of well being, 
glee, increased motivation and self-esteem (Mazzeo, 2016). Moreover, the athlete doesn’t get bored during 
the training. Narcotics have a calming effect on the psyche as well as beta-blockers reduce the anxiety and 
stress. Corticosteroids have, instead, a stimulating effect like alcohol. Moreover, to corticosteroids are 
recognized: euphoria, increased sociability and sense of well-being. Cannabinoids, such as cannabis, 
hashish and marijuana, cause changes in mood and perception, euphoria, happiness, relaxation and deep 
sleep and reducing anxiety. They are considered drug to use social-recreational. (Technische Universität 
München; Tevis , 2014). 
 
WADA, in 2004, drew up a Code that is constantly emended. The Code explains the definition of doping and 
contains sanctions too. Others instruments used to contrast doping are the accredited laboratories, the 
biological passport and the ADAMS (Overbye et al., 2013). 
 
The laboratories have an important role in the discovery of new substances. They also determine the 
quantitative of those substances, carry out anti-doping tests. Currently, there are 32 laboratories in the World 
(Table 4) (Valkenburg et. al, 2014). 
 
The Biological Passport is a tool for indirect detection of the presence of a doping substance in biological 
samples of an athlete. With it, in fact, the changes of certain bio-markers of doping are recorded and 
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monitored. If the data, combined with the personal data localization in a given period, exceeded a certain 
range, the athlete would assume the banned substances (Lippi et al. 2008; Thevis et al, 2014). 
 
The Anti-Doping Administration and Management System (ADAMS) is an on-line database system where 
are recorded all data: laboratory results, therapeutic use exemptions (TUEs) and information on anti-doping 
rule violations. It allows the sharing of information amongst the organizations and promotes efficiency, 
transparency and effectiveness in all anti-doping activities (Møller, et al, 2014). 
 
Table 4. Anti- Doping laboratories in the World 
State City Note 
AUSTRALIA Sydney  
AUSTRIA Seibersdorf  
BELGIUM Ghent  
BRAZIL Rio de 
Janeiro 
 
CANADA Montreal  
PEOPLE’S REPUBLIC 
OF CHINA 
Beijing  
COLOMBIA Bogota The WADA accreditation of the Laboratorio de Control al 
Dopaje Coldeportes Nacional Bogota – Colombia 
was suspended from conducting anti-doping testing for a 
period of six months effective 20 February 2017. 
Following the expiry of this initial suspension period, the 
laboratory’s suspension was extended for an 
additional period of up to six months to address outstanding 
non-compliances. 
CUBA Havana  
FINLAND Helsinki  
FRANCE Paris  
GERMANY Cologne  
 Kreischa  
GREAT BRITAIN London  
GREECE Athens  
INDIA New Delhi  
ITALY Roma  
JAPAN Tokyo  
KOREA Seoul  
MEXICO Mexico The WADA accreditation of the Laboratorio Nacional de 
Prevencion y Control del Dopaje-CONADE, Mexico 
was suspended from conducting anti-doping testing for a 
period of six months effective 23 November 2016. 
Following the expiry of this initial suspension period, the 
laboratory’s suspension was extended for an 
additional period of up to six months to address outstanding 
non-compliances. 
NORWAY Oslo  
POLAND Warsaw  
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PORTUGAL Lisbon suspended from conducting anti-doping testing for an 
undetermined period effective as of 15, April 2016. 
QATAR Doha  
ROMANIA Bucharest  
SPAIN Barcelona  
 Madrid suspended from conducting anti-doping testing for an 
undetermined period effective as of 6, June 2016. 
SWEDEN Stockholm  
SWITZERLAND Lausanne  
THAILAND Bangkok  
TURKEY Ankara  
UNITED STATES Los Angeles  
 Salt Lake 
City 
 
 
CONCLUSIONS 
 
Doping is a phenomenon characterized by clandestineness (Mazzeo et al. 2016). The anti-doping tests 
provide insufficient data for statistical extrapolations and accurate estimates of the phenomenon, because of 
the small number of athletes tested and the imprecision of the methods of research (Sadeghi Pour, et al., 
2009). The lack of statistical significance is due precisely to the low sampling of the tests, compared to tens 
of millions of athletes engaged in sports practices also outside of the vertices competitive (Ferrara, 2004). 
 
Athletes subject to Italian and WORLD drug antidoping testing may be subject to both in- and out-of-
competition testing. At the present, the tests are based on urine samples (Mazzeo et al, 2018) . Blood tests 
should enable verification of the level of haematocrit or haemoglobin. This type of analyses based on more 
specific parameters (direct or indirect) could well reveal forms of doping that cannot be detected in urine (de 
Me ́rode et. al, 1999). 
 
To confirm what said up to now, on April 2006, DOXA Institute submitted 508 athletes to an anonymous 
questionnaire about beliefs on and attitude on doping of Italian athletes. They “confessed” that the tests are 
infrequently and poorly effective and they should be more frequent and follow a different protocol (Tavani et 
al., 2012). 
 
Inappropriately, today, although the technological advancement that characterizes the field of scientific 
research, the analytical methods are not sufficiently dependable for the search of the complete group of 
substances included in the anti-doping lists (Mazzeo et al., 2016). 
 
Another inquiry is the great difficulty to anticipate the moves of the opponent and this, therefore, is not easy 
to understand what new substances will be taken and what new methods will be adopted (Ministero della 
Salute 2013). Anyway, close collaboration among the accredited laboratories would enable them to keep up 
to date and exchange new techniques. Closer ties with the pharmaceutical industry and those involved in 
basic research are also vital if they are to be able to anticipate new tendencies and forms of doping by means 
of a sort of scientific “vigil” (Marcley et al, 20. The instrumentation and measurements industry would also be 
able to give them the benefit of recent progress in their domain (de Mérode, et al. 1999). 
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Furthermore, the purposes of the World Anti-Doping Program and the Code are to protect the athlete’s 
fundamental right to participate in doping-free sport and thus promoting health, fairness and equality for 
athletes world wide. Potentially risks to health by doping are taken in the pursuit of sporting excellence 
(Mazzeo, et. al., 2015) . The increasing profile of sport for athletes with a disability, and its potential rewards, 
has led some athletes to seek improved performance through the administration of prohibited substances. 
 
Moreover, is essential for economic and social development that the health sector is responsible for: 
developing and implementing national and subnational health strategies (Mazzeo, 2016). 
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